These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 2019417

  • 1. Morphological evidence for chronic mast cell activation after prolonged exposure with supernatants from chronic graft-versus-host splenocytes.
    Levi-Schaffer F, Segal V, Mekori YA, Claman HN, Hammel I.
    Immunol Lett; 1991 Jan; 27(1):13-8. PubMed ID: 2019417
    [Abstract] [Full Text] [Related]

  • 2. Regulation of the functional activity of mast cells and fibroblasts by mononuclear cells in murine and human chronic graft-vs.-host disease.
    Levi-Schaffer F, Segal V, Barak V, Rubinchik E, Nagler A.
    Exp Hematol; 1997 Mar; 25(3):238-45. PubMed ID: 9091300
    [Abstract] [Full Text] [Related]

  • 3. Histamine release from mouse and rat mast cells cultured with supernatants from chronic murine graft-vs-host splenocytes.
    Levi-Schaffer F, Mekori YA, Segal V, Claman HN.
    Cell Immunol; 1990 Apr 15; 127(1):146-58. PubMed ID: 1690607
    [Abstract] [Full Text] [Related]

  • 4. Nedocromil sodium ameliorates skin manifestations in a murine model of chronic graft-versus-host disease.
    Levi-Schaffer F, Goldenhersh MA, Segal V, Nagler A.
    Bone Marrow Transplant; 1997 Apr 15; 19(8):823-8. PubMed ID: 9134176
    [Abstract] [Full Text] [Related]

  • 5. Ketotifen therapy in chronic graft-versus-host disease (cGVHD): effect on mast cells and fibroblasts.
    Nagler A, Segal V, Slavin S, Levi-Schaffer F.
    Clin Exp Immunol; 1995 Jun 15; 100(3):529-35. PubMed ID: 7539727
    [Abstract] [Full Text] [Related]

  • 6. Hepatic homing of mononuclear inflammatory cells isolated during murine chronic graft-vs-host disease.
    Howell CD, Yoder T, Claman HN, Vierling JM.
    J Immunol; 1989 Jul 15; 143(2):476-83. PubMed ID: 2472440
    [Abstract] [Full Text] [Related]

  • 7. Mast cell "disappearance" in chronic murine graft-vs-host disease (GVHD)-ultrastructural demonstration of "phantom mast cells".
    Claman HN, Choi KL, Sujansky W, Vatter AE.
    J Immunol; 1986 Sep 15; 137(6):2009-13. PubMed ID: 3745920
    [Abstract] [Full Text] [Related]

  • 8. Mast Cell and Fibroblast Functional Activity Are Affected by Immunocompetent Cells in Chronic Grafts-vs.-Host Disease.
    Levi-Schaffer F, Segal V, Nagler A.
    Int Arch Allergy Immunol; 1992 Sep 15; 99(2-4):238-241. PubMed ID: 34167208
    [Abstract] [Full Text] [Related]

  • 9. Suppressor function of liver mononuclear cells isolated during murine chronic graft-vs-host disease. II. Role of prostaglandins and interferon-gamma.
    Howell CD, Yoder TY, Vierling JM.
    Cell Immunol; 1992 Mar 15; 140(1):54-66. PubMed ID: 1531454
    [Abstract] [Full Text] [Related]

  • 10. Effect of coculture of rodent mast cells with murine chronic graft-versus-host disease (cGVHD)-derived fibroblasts.
    Levi-Schaffer F, Segal V, Baram D, Mekori YA.
    J Allergy Clin Immunol; 1992 Feb 15; 89(2):501-9. PubMed ID: 1371296
    [Abstract] [Full Text] [Related]

  • 11. Chronic graft-versus-host disease as a model for scleroderma. II. Mast cell depletion with deposition of immunoglobulins in the skin and fibrosis.
    Claman HN, Jaffee BD, Huff JC, Clark RA.
    Cell Immunol; 1985 Aug 15; 94(1):73-84. PubMed ID: 4016962
    [Abstract] [Full Text] [Related]

  • 12. Mast cells and fibroblasts: two interacting cells.
    Rubinchik E, Levi-Schaffer F.
    Int J Clin Lab Res; 1994 Aug 15; 24(3):139-42. PubMed ID: 7819593
    [Abstract] [Full Text] [Related]

  • 13. Prostaglandin E2 production by chronic graft-versus-host disease dermal fibroblasts.
    Levi-Schaffer F, Baram D, Segal V, Garbuzenko E, Lew S, Mekori YA.
    Immunol Lett; 1995 Nov 15; 48(1):11-15. PubMed ID: 8847084
    [Abstract] [Full Text] [Related]

  • 14. Cutaneous mast cell depletion and recovery in murine graft-vs-host disease.
    Choi KL, Giorno R, Claman HN.
    J Immunol; 1987 Jun 15; 138(12):4093-101. PubMed ID: 2953799
    [Abstract] [Full Text] [Related]

  • 15. Increased ICAM-1 expression in the early stages of murine chronic graft-versus-host disease.
    Schiltz PM, Giorno RC, Claman HN.
    Clin Immunol Immunopathol; 1994 May 15; 71(2):136-41. PubMed ID: 7910123
    [Abstract] [Full Text] [Related]

  • 16. Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice.
    Nagler A, Pines M, Abadi U, Pappo O, Zeira M, Rabbani E, Engelhardt D, Ohana M, Chowdhury NR, Chowdhury JR, Ilan Y.
    Hepatology; 2000 Mar 15; 31(3):641-8. PubMed ID: 10706554
    [Abstract] [Full Text] [Related]

  • 17. Suppressor function of hepatic mononuclear inflammatory cells during murine chronic graft-vs-host disease. I. Macrophage-enriched cells mediate suppression in the liver.
    Howell CD, Yoder TD, Vierling JM.
    Cell Immunol; 1991 Jan 15; 132(1):256-68. PubMed ID: 1829654
    [Abstract] [Full Text] [Related]

  • 18. Bone marrow-derived cultured mast cells and peritoneal mast cells as targets of a growth activity secreted by BALB/3T3 fibroblasts.
    Jozaki K, Kuriu A, Hirota S, Onoue H, Ebi Y, Adachi S, Ma JY, Tarui S, Kitamura Y.
    Exp Hematol; 1991 Mar 15; 19(3):185-90. PubMed ID: 1847337
    [Abstract] [Full Text] [Related]

  • 19. Mast cell depletion in murine chronic graft-versus-host disease.
    Claman HN.
    J Invest Dermatol; 1985 Apr 15; 84(4):246-8. PubMed ID: 3981034
    [Abstract] [Full Text] [Related]

  • 20. Alleviation of chronic GVHD in mice by oral immuneregulation toward recipient pretransplant splenocytes does not jeopardize the graft versus leukemia effect.
    Ilan Y, Margalit M, Ohana M, Gotsman I, Rabbani E, Engelhardt D, Nagler A.
    Hum Immunol; 2005 Mar 15; 66(3):231-40. PubMed ID: 15784461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.